title: Association between MspI polymorphism of the APO AI gene and Type 2 diabetes mellitus.
abstract: OBJECTIVE
  Genes of the Apo AI/CIII/AIV cluster on chromosome 11 have been related to plasma lipid patterns. The close relationship between carbohydrate metabolism and lipid metabolism warrants investigation of the association between this cluster and Type 2 diabetes mellitus. We therefore examined the possible association between polymorphisms of this cluster and Type 2 diabetes mellitus as part of a study of the prevalence of diabetes and the metabolic syndrome in southern Spain.
  
  
  METHODS
  A total of 1224 persons were selected randomly from the town of Pizarra in the province of Malaga, southern Spain. The sample errors for the prevalence of Type 2 diabetes mellitus and the three polymorphisms studied were all < or = 4%. All subjects underwent phenotyping after an oral glucose tolerance test (75 g) (WHO 1998 criteria) and the XmnI and MspI polymorphisms of Apo AI and the SstI polymorphism of Apo CIII were genotyped.
  
  
  RESULTS
  Those subjects with the mutated AA genotype of the MspI polymorphism (-75 G-->A) of Apo AI had a greater risk of impaired glucose tolerance [odds ratio (OR) = 1.95, CI = 1.02-3.8, P = 0.05], Type 2 diabetes mellitus, both known (OR = 7.38, CI = 1.3-39.7, P = 0.02) and unknown (OR = 3.7, CI = 1.4-9.9, P = 0.009). This risk was independent of age, sex, obesity, triglyceride level, HDL cholesterol and pattern of insulin resistance.
  
  
  CONCLUSIONS
  Pending confirmation in prospective studies, the AA genotype of the MspI polymorphism of the Apo AI gene, within the Apo A-I/C-III/A-IV cluster, seems to be a risk factor for Type 2 diabetes mellitus.
authors.affiliation: Endocrinology and Nutrition Service, Hospital Carlos Haya, Malaga, Spain.
authors.forename: S
authors.initials: S
authors.lastname: Morcillo
authors.forename: F
authors.initials: F
authors.lastname: Cardona
authors.forename: G
authors.initials: G
authors.lastname: Rojo-Martínez
authors.forename: I
authors.initials: I
authors.lastname: Esteva
authors.forename: M S
authors.initials: MS
authors.lastname: Ruíz-de-Adana
authors.forename: F
authors.initials: F
authors.lastname: Tinahones
authors.forename: J M
authors.initials: JM
authors.lastname: Gómez-Zumaquero
authors.forename: F
authors.initials: F
authors.lastname: Soriguer
mesh_terms: D000328:Adult; D000368:Aged; D016632:Apolipoprotein A-I / Q000097:blood / Q000235:genetics*; D001056:Apolipoproteins C / Q000097:blood / Q000235:genetics*; D003430:Cross-Sectional Studies; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D011110:Polymorphism, Genetic; D011446:Prospective Studies; D013030:Spain
chemical_list: D016632:Apolipoprotein A-I; D001056:Apolipoproteins C